A tumor-derived metabolite primes the leptomeningeal pre-metastatic niche
Trending
- Daraxonrasib Receives FDA Breakthrough Therapy Status in 1L Metastatic PDAC
- Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial
- FDA Approves Shorter Monitoring for First Two Tarlatamab Doses in ES-SCLC
- How Does Azacitidine/Venetoclax Impact Hospital Burden in AML?
- WCLC 2026: The Presentations That May Shape The Future of NSCLC
- When Helping Becomes Controlling: What I Learned About Fear and Love
- Social media is promoting harmful attitudes towards sun exposure | Skin cancer
- New Order keyboardist Gillian Gilbert announces she is ‘living with cancer’ | New Order
Tuesday, September 15
